stage IV bladder cancer
Showing 26 - 50 of >10,000
Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral
Recruiting
- Locally Advanced Renal Pelvis Urothelial Carcinoma
- +20 more
- Atezolizumab
- +2 more
-
Duarte, California
- +16 more
Aug 10, 2022
Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)
Active, not recruiting
- Solid Neoplasm
- +16 more
- Carboplatin
- +2 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8, Stage III Bladder Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Stage I Bladder Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Urinary Bladder Tumors Trial in Worldwide (Durvalumab, Olaparib, Placebo)
Active, not recruiting
- Urinary Bladder Neoplasms
- Durvalumab
- +2 more
-
Birmingham, Alabama
- +44 more
Dec 21, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +17 more
- Avelumab
- +3 more
-
Auburn, California
- +111 more
Aug 17, 2022
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best
Not yet recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Best Practice
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 18, 2023
Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,
Not yet recruiting
- Recurrent Bladder Carcinoma
- +2 more
- Pharmacokinetic Study
- Recombinant EphB4-HSA Fusion Protein
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle
Recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Lymphadenectomy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma Trial in United States (procedure, other,
Recruiting
- Stage IV Bladder Urothelial Carcinoma
- +2 more
- Computed Tomography
- +4 more
-
Duarte, California
- +8 more
Nov 19, 2022
Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,
Recruiting
- Sarcoma, Synovial
- +8 more
- CYCLOPHOSPHAMIDE and FLUDARABIN
- +3 more
-
Jerusalem, IsraelHadassah Medical Organization
Mar 15, 2022
Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- +2 more
- PDD-TURBT with hexaminolevulinate (Hexvix®)
- Power Led Saphira (TM) from KARL STORZ
- (no location specified)
Jul 24, 2023
Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG
Active, not recruiting
- Recurrent Bladder Carcinoma
- +3 more
- BCG Solution
- +3 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2022
Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +10 more
- Discussion
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 24, 2023
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023
Urine-based Molecular Testing vs Cystoscopy for Surveillance of
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- +2 more
- CxBladder Monitor
- Cystoscopy
-
Scottsdale, Arizona
- +2 more
Nov 14, 2023
Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in
Completed
- Distal Urethral Cancer
- +10 more
- Gemcitabine hydrochloride
- +3 more
-
Springfield, Missouri
- +1 more
Sep 17, 2020
Can Second Resection for pT1 Bladder Cancer be Avoided After
Recruiting
- Bladder Cancer Stage I
- Avoid second resection after initial complete resection
-
Mansoura, Dakahlia, EgyptUrology and nephrology center, Mansoura University
Aug 2, 2023
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8 Trial in Buffalo (Behavioral
Recruiting
- Stage 0a Bladder Cancer AJCC v8
- +2 more
- Behavioral Dietary Intervention
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 26, 2022
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Metastatic Urothelial Carcinoma, Platinum-Resistant Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8 Trial in United States
Recruiting
- Metastatic Urothelial Carcinoma
- +2 more
- Atezolizumab
- +3 more
-
Bloomington, Illinois
- +49 more
Jan 25, 2023
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Epacadostat
- +2 more
-
Minneapolis, Minnesota
- +1 more
Jan 27, 2023
Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)
Not yet recruiting
- Colorectal Cancer
- FOLFOX , FOLFIRI or FOLFOXIRI regimens
- FOLFOX regimen
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 26, 2023
Bladder Cancer Trial in Fairway, Kansas City (Ascorbic Acid)
Active, not recruiting
- Bladder Cancer
- Ascorbic Acid
-
Fairway, Kansas
- +2 more
Sep 21, 2022